BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17342087)

  • 1. Study of matrix metalloproteinases and their inhibitors in breast cancer.
    Vizoso FJ; González LO; Corte MD; Rodríguez JC; Vázquez J; Lamelas ML; Junquera S; Merino AM; García-Muñiz JL
    Br J Cancer; 2007 Mar; 96(6):903-11. PubMed ID: 17342087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.
    González LO; Pidal I; Junquera S; Corte MD; Vázquez J; Rodríguez JC; Lamelas ML; Merino AM; García-Muñiz JL; Vizoso FJ
    Br J Cancer; 2007 Oct; 97(7):957-63. PubMed ID: 17848954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.
    Gonzalez LO; Corte MD; Vazquez J; Junquera S; Sanchez R; Viña A; Rodriguez JC; Lamelas ML; Vizoso F
    Histopathology; 2008 Oct; 53(4):403-15. PubMed ID: 18983606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
    Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
    Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas.
    Del Casar JM; González LO; Alvarez E; Junquera S; Marín L; González L; Bongera M; Vázquez J; Vizoso FJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):39-52. PubMed ID: 19241156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
    Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
    J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin.
    Massi D; Franchi A; Ketabchi S; Paglierani M; Pimpinelli N; Santucci M
    Hum Pathol; 2003 Jan; 34(1):80-8. PubMed ID: 12605370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
    Jones JL; Glynn P; Walker RA
    J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.
    Kim GE; Lee JS; Choi YD; Lee KH; Lee JH; Nam JH; Choi C; Kim SS; Park MH; Yoon JH; Kweon SS
    BMC Cancer; 2014 Dec; 14():959. PubMed ID: 25510449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer.
    Thomas P; Khokha R; Shepherd FA; Feld R; Tsao MS
    J Pathol; 2000 Feb; 190(2):150-6. PubMed ID: 10657012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoexpression of matrix metalloproteinases and their inhibitors in different areas of oral squamous cell carcinoma.
    Suarez-Roa ML; Asbun-Bojalil J; Ruiz-Godoy LM; Meneses-García AA
    Aust Dent J; 2012 Sep; 57(3):300-7. PubMed ID: 22924352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
    Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy.
    Rahko E; Jukkola A; Melkko J; Paavo P; Bloigu R; Talvensaari-Mattila A; Turpeenniemi-Hujanen T
    Anticancer Res; 2004; 24(6):4247-53. PubMed ID: 15736480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion.
    Zhao YG; Xiao AZ; Park HI; Newcomer RG; Yan M; Man YG; Heffelfinger SC; Sang QX
    Cancer Res; 2004 Jan; 64(2):590-8. PubMed ID: 14744773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
    González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
    Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?
    Séguier S; Gogly B; Bodineau A; Godeau G; Brousse N
    J Periodontol; 2001 Oct; 72(10):1398-406. PubMed ID: 11699482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study.
    Hirano H; Tsuji M; Kizaki T; Sashikata T; Yoshi Y; Okada Y; Mori H
    Med Electron Microsc; 2002 Mar; 35(1):16-23. PubMed ID: 12111403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
    Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC
    Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.